Sanofi India · NSE: SANOFI · BSE: 500674
Q1 FY21 results · Apr–Jun 2020
Sanofi India reported revenue from operations of ₹710.50 crore (down 5.0% from Q1 FY20) and net profit of ₹136.30 crore (up 39.9% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a standalone basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 710.50 | 747.90 | −5.0% | 784.50 | −9.4% |
| Other income | 29.20 | 23.40 | +24.8% | 29.50 | −1.0% |
| Total income | 739.70 | 771.30 | −4.1% | 814.00 | −9.1% |
| Profit before tax | 186.50 | 155.20 | +20.2% | 134.60 | +38.6% |
| Net profit for the period | 136.30 | 97.40 | +39.9% | 85.40 | +59.6% |
| EPS, basic (₹) | 59.18 | 42.29 | +39.9% | 37.08 | +59.6% |
| Net margin (%) | 19.2 | 13.0 | 10.9 |
Standalone
- Filed with BSE
- 29 Jul 2020, 14:46 IST
- Board meeting
- 28 Jul 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE